Cover Image

Improving access to gene therapy for rare diseases

Saved in:

Bibliographic Details
Main Authors:	Thomas A. Fox (Author), Claire Booth (Author)
Format:	Book
Published:	The Company of Biologists, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gene therapy for rare haematological and neurometabolic paediatric diseases
by: Vera Gallo, et al.
Published: (2024)

Innovation in Informatics to Improve Clinical Care and Drug Accessibility for Rare Diseases in China
by: Peng Liu, et al.
Published: (2021)

Improving access to gene therapies: a holistic view of current challenges and future policy solutions in the United States
by: Tyler D Wagner, et al.
Published: (2024)

Market Access Challenges and Solutions in Cell and Gene Therapy in The Netherlands
by: Rimma Velikanova, et al.
Published: (2024)

Access to medicines for rare diseases: A European regulatory roadmap for academia
by: Noa Rosenberg, et al.
Published: (2023)

Improving diagnosis for rare diseases: the experience of the Italian undiagnosed Rare diseases network
by: Marco Salvatore, et al.
Published: (2020)

Setmelanotide - from genes to targeted therapy in some rare forms of obesity
by: Dawid Frączkowski
Published: (2021)

Phenotype-driven gene prioritization for rare diseases using graph convolution on heterogeneous networks
by: Aditya Rao, et al.
Published: (2018)

Generating Evidence from Expanded Access Use of Rare Disease Medicines: Challenges and Recommendations
by: Tobias B. Polak, et al.
Published: (2022)

Improving global access to medicines for non-communicable diseases
by: David Beran, et al.
Published: (2014)

Improving the safety of cell therapy with the TK-suicide gene
by: Raffaella eGreco, et al.
Published: (2015)

Evaluating the effectiveness and cost-effectiveness of British Sign Language Improving Access to Psychological Therapies: an exploratory study
by: Alys Young, et al.
Published: (2017)

Gene therapy for polygenic or complex diseases
by: Tingting Wu, et al.
Published: (2024)

Gene Therapy Tools for Brain Diseases
by: Selene Ingusci, et al.
Published: (2019)

Suprachoroidal Delivery of Small Molecules, Nanoparticles, Gene and Cell Therapies for Ocular Diseases
by: Chen-rei Wan, et al.
Published: (2021)

Improving the Safety of Cell Therapy Products by Suicide Gene Transfer
by: Antonio eDi Stasi, et al.
Published: (2014)

Rare Monogenic Diseases: Molecular Pathophysiology and Novel Therapies
Published: (2023)

Advancing Genomics for Rare Disease Diagnosis and Therapy Development
Published: (2020)

Gene therapy for pediatric genetic kidney diseases
by: Yi Lu, et al.
Published: (2023)

Rare Kidney Diseases New Translational Research Approach to Improve Diagnosis and Therapy
Published: (2020)

Gene therapies for osteoarthritis: progress and prospects
by: Anais Defois, et al.
Published: (2024)

Improving translational studies: lessons from rare neuromuscular diseases
by: Dominic Wells
Published: (2015)

Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectors
by: James A. Williams, et al.
Published: (2023)

A case of misalignment: the perspectives of local and national decision-makers on the implementation of psychological treatment by telephone in the Improving Access to Psychological Therapies Service
by: Kelly Rushton, et al.
Published: (2019)

Moving toward improved access to medicines and health technologies for cardiovascular disease
by: Nora Giron, et al.
Published: (2023)

Editorial: Improving the safety of cell therapy products by suicide gene transfer
by: Elodie eBole-Richard, et al.
Published: (2015)

Lower Healthcare Access and Its Association With Individual Factors and Health-Related Quality of Life in Adults With Rare Diseases in Switzerland
by: Susanne Wehrli, et al.
Published: (2024)

Improving Chronic Disease Outcomes Through Medication Therapy Management in Federally Qualified Health Centers
by: Jennifer L. Rodis, et al.
Published: (2017)

Pharmacotherapeutic Patterns and Patients' Access to Pharmacotherapy for Some Rare Diseases in Bulgaria - A Pilot Comparative Study
by: Maria Kamusheva, et al.
Published: (2021)

ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY
by: D. V. Fedyaev, et al.
Published: (2015)

Editorial: Advancing Genomics for Rare Disease Diagnosis and Therapy Development
by: Zhichao Liu, et al.
Published: (2020)

Elevated Intraocular Pressure and Glaucomatous Optic Neuropathy: Genes to Disease Mechanisms, Therapeutic Drugs, and Gene Therapies
by: Najam A. Sharif
Published: (2023)

From gene to treatment: supporting rare disease translational research through model systems
by: Julija Hmeljak, et al.
Published: (2019)

Inequitable access to an outpatient parenteral antimicrobial therapy service: linked cross-sectional study
by: Colin Sumpter, et al.
Published: (2020)

The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson's disease
by: Jesper Jørgensen, et al.
Published: (2018)

Correction to: A case of misalignment: the perspectives of local and national decision-makers on the implementation of psychological treatment by telephone in the Improving Access to Psychological Therapies Service
by: Kelly Rushton, et al.
Published: (2020)

Effectiveness of a rapid access musculoskeletal service in rural primary care
by: Declan Fox
Published: (2023)

Improving Access to Oral Healthcare
Published: (2022)

Innovations in improving access to contraceptives
by: C. Cissé, et al.
Published: (2015)

Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies
by: Mégane Brusson, et al.
Published: (2023)